Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • ENT Guidelines
    • NICE sore throat...

    NICE sore throat guideline: antimicrobial prescribing

    Written by Dr. Kamal Kant Kohli Kohli Published On 2018-03-09T19:01:52+05:30  |  Updated On 9 March 2018 7:01 PM IST
    NICE sore throat guideline: antimicrobial prescribing

    NICE has released its new guidelines for managing acute sore throat and antimicrobial prescribing.All people with acute sore throat should be aware that acute sore throat (including pharyngitis and tonsillitis) is self‑limiting and often triggered by a viral infection of the upper respiratory tract.Its symptoms can last for around 1 week, but most people will get better within this time without antibiotics, regardless of cause (bacteria or virus).It is therefore important that clinicians should assess and manage children under 5 who present with fever as outlined in the NICE guideline on fever in under 5s.They may use FeverPAIN or Centor criteria to identify people who are more likely to benefit from an antibiotic and manage in line with recommendations below.If at any time symptoms worsen rapidly or significantly alternative diagnoses such as scarlet fever or glandular fever should be considered.


    Key Recommendations:

    People who are unlikely to benefit from an antibiotic (FeverPAIN score of 0 or 1, or Centor score of 0, 1 or 2):



    • Do not offer an antibiotic prescription

    • As well as the general advice mentioned above, give advice about:

      • an antibiotic not being needed

      • seeking medical help if symptoms worsen rapidly or significantly, do not start to improve after 1 week, or the person becomes systemically very unwell



    • See the evidence and committee discussion on no antibiotic.


    People who may be more likely to benefit from an antibiotic (FeverPAIN score of 2 or 3)



    • Consider no antibiotic prescription with advice or a back-up antibiotic prescription, taking account of:

      • evidence that antibiotics make little difference to how long symptoms last (on average, they shorten symptoms by about 16 hours)

      • evidence that most people feel better after 1 week, with or without antibiotics

      • the unlikely event of complications if antibiotics are withheld

      • possible adverse effects, particularly diarrhoea and nausea



    • When a back-up antibiotic prescription is given, as well as the general advice in recommendation , give advice about:

      • an antibiotic not being needed immediately

      • using the back-up prescription if symptoms do not start to improve within 3 to 5 days or if they worsen rapidly or significantly at any time

      • seeking medical help if symptoms worsen rapidly or significantly or the person becomes systemically very unwell




    People who are most likely to benefit from an antibiotic (FeverPAIN score of 4 or 5, or Centor scoreof 3 or 4)



    • Consider an immediate antibiotic prescription (see recommendation for choice of antibiotic), or a back-up antibiotic prescription with advice (see recommendation ), taking account of:

      • the unlikely event of complications if antibiotics are withheld

      • possible adverse effects, particularly diarrhoea and nausea



    • When an immediate antibiotic prescription is given, as well as the general advice in recommendation , give advice about seeking medical help if symptoms worsen rapidly or significantly or the person becomes systemically very unwell

    • See the evidence and committee discussion on back-up antibiotics and choice of antibiotic


    People who are systemically very unwell, have symptoms and signs of a more serious illness or condition, or are at high-risk of complications



    • Offer an immediate antibiotic prescription (see recommendation for choice of antibiotic) with advice or further appropriate investigation and management

    • Refer people to hospital if they have acute sore throat associated with any of the following:

      • a severe systemic infection (see the NICE guideline on sepsis)

      • severe suppurative complications (such as quinsy [peri-tonsillar abscess] or cellulitis, parapharyngeal abscess or retropharyngeal abscess or Lemierre syndrome)



    • See the evidence and committee discussion on choice of antibiotic


    Self-care


    All people with acute sore throat



    • Consider paracetamol for pain or fever, or if preferred and suitable, ibuprofen.

    • Advise about the adequate intake of fluids.

    • Explain that some adults may wish to try medicated lozenges containing either a local anaesthetic, a non-steroidal anti-inflammatory drug (NSAID) or an antiseptic. However, they may only help to reduce pain by a small amount.

    • Be aware that no evidence was found on non-medicated lozenges, mouthwashes, or local anaesthetic mouth spray used on its own.

    • See the evidence and committee discussion on self-care


    Choice of antibiotic



    • When prescribing an antibiotic for acute sore throat:

      • follow table 1 for adults aged 18 years and over

      • follow table 2 for children and young people under 18 years

































    Table 1 Antibiotics for adults aged 18 years and over
    Antibiotic*Dosage and course length for adults†
    First choice
    Phenoxymethylpenicillin500 mg four times a day or 1000 mg twice a day for 5 to 10 days
    Alternative first choices for penicillin allergy or intolerance3
    Clarithromycin250 mg to 500 mg twice a day for 5 days
    Erythromycin250 mg to 500 mg four times a day or 500 mg to 1,000 mg twice a day for 5 days
    * See BNF for appropriate use and dosing in specific populations, for example, hepatic impairment, renal impairment, pregnancy and breastfeeding.

    † Doses given are by mouth using immediate-release medicines, unless otherwise stated.

    ‡ Erythromycin is preferred in women who are pregnant.
































    Table 2 Antibiotics for children and young people under 18 years
    Antibiotic§Dosage and course length for children and young peoplel
    First choice
    Phenoxymethylpenicillin1 to 11 months, 6 mg four times a day or 125 mg twice a day for 5 to 10 days

    1 to 5 years, 125 mg four times a day or 250 mg twice a day for 5 to 10 days

    6 to 11 years, 250 mg four times a day or 500 mg twice a day for 5 to 10 days

    12 to 17 years, 500 mg four times a day or 1,000 mg twice a day for 5 to 10 days
    Alternative first choices for penicillin allergy or intolerance¶
    Clarithromycin1 month to 11 years:

    Under 8 kg, mg/kg twice a day for 5 days

    8 to 11 kg, 6 mg twice a day for 5 days

    12 to 19 kg, 125 mg twice a day for 5 days

    20 to 29 kg, 18 mg twice a day for 5 days

    30 to 40 kg, 250 mg twice a day for 5 days

    or

    12 to 17 years, 250 mg to 500 mg twice a day for 5 days
    Erythromycin1 month to 1 year, 125 mg four times a day or 250 mg twice a day for 5 days

    2 to 7 years, 250 mg four times a day or 500 mg twice a day for 5 days

    8 to 17 years, 250 mg to 500 mg four times a day or 500 mg to 1000 mg twice a day for 5 days
    § See BNF for children for appropriate use and dosing in specific populations, for example hepatic impairment and renal impairment

    l The age bands apply to children of average size and, in practice, the prescriber will use the age bands in conjunction with other factors such as the severity of the condition and the child’s size in relation to the average size of children of the same age. Doses given are by mouth using immediate‑release medicines, unless otherwise stated

    ¶ Erythromycin is preferred in young women who are pregnant



    • See the evidence and committee discussion on choice of antibiotic and antibiotic course length


    Terms used in the guideline


    People with a sore throat caused by streptococcal bacteria are more likely to benefit from antibiotics. FeverPAIN or Centor criteria are clinical scoring tools that can help to identify the people in whom this is more likely

    FeverPAIN criteria



    • F ever (during previous 24 hours)

    • P urulence (pus on tonsils)

    • A ttend rapidly (within 3 days after onset of symptoms)

    • Severely I nflamed tonsils

    • N o cough or coryza (inflammation of mucus membranes in the nose)


    Each of the FeverPAIN criteria score 1 point (maximum score of 5). Higher scores suggest more severe symptoms and likely bacterial (streptococcal) cause. A score of 0 or 1 is thought to be associated with a 13 to 18% likelihood of isolating streptococcus. A score of 2 or 3 is thought to be associated with a 34 to 40% likelihood of isolating streptococcus. A score of 4 or 5 is thought to be associated with a 62 to 65% likelihood of isolating streptococcus

    For more details click on the link : https://www.nice.org.uk/guidance/ng84
    cellulitisnon-steroidal anti-inflammatory drugparapharyngealpharyngitistonsillitis

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Dr. Kamal Kant Kohli Kohli
    Dr. Kamal Kant Kohli Kohli
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok